Sensex deep in the red as Covid 2.0 brings D-St to its knees: Key reasons behind crash
Since the second wave of the pandemic is turning out to be much worse than expected, there is uncertainty about its impact on the economy and markets.
By Shubham Raj, ETMarkets.com | Updated:
NEW DELHI: A non-stop jump in Covid-19 infections spooked Indian investors who sold mercilessly on Monday, dragging bluechip sharply lower. Weak global cues also hurt the investor sentiment on Dalal Street.
Fear gauge India VIX spiked over 13 per cent.
Since the second wave of the pandemic is turning out to be much worse than expected, there is uncertainty about its impact on the economy and markets. The situation may improve if cases peak soon and start coming down. But currently, this is a negative, said an analyst.
“The bad health situation and INR depreciation have improved prospects for the pharma and IT sectors, which are likely to remain resilient even during a market downturn. Economy-facing stocks are likely to be under pressure," said VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services.
FACTORS DRAGGING MARKET
Covid rampage: India added 1,52,879 fresh infections reported since yesterday, setting another grim one-day record as the country's Covid tally reached over 1.33 crore cases on Sunday. 839 deaths in the last 24 hours pushed the total death count to 1.69 lakh.
Yields surge: US Treasury yields climbed on Friday after higher-than-expected March producer price data showed inflation had risen, echoing other reports that said the world's largest economy was on a steady road to recovery from the pandemic.
How are the blue chip stocks doing?
After opening in the red, benchmark indices nosedived as a broad-based selloff deepened led by financial stocks. BSE flagship Sensex ended 1,707.94 points or 3.44 per cent lower at 47,883.38. NSE benchmark Nifty followed, tumbling 524.05 points or 3.53 per cent to close at 14,310.80.
In the 50-share pack Nifty, Cipla was the biggest gainer, up 2.14 per cent. Infosys, Dr Reddy’s Laboratories and Divi’s Laboratories were among other gainers.
Broader markets
Broader market indices were trading with cuts deeper than their headline peers in morning deals. Nifty Smallcap was down 4.52 per cent while Nifty Midcap declined 4.42 per cent. The broadest index on NSE -- the Nifty 500 index -- was down 2.97 per cent.
Global markets
MSCI's broadest index of Asia-Pacific shares outside Japan was off 0.6 per cent in slow trade. Tokyo's Nikkei edged down 0.5 per cent, while South Korean stocks were near flat.
Chinese blue chips eased 0.9 per cent ahead of a rush of economic figures from the country.
Nasdaq futures slipped 0. per cent on Monday, as did S&P 500 futures. EUROSTOXX 50 futures dithered on either side of flat, while FTSE futures were down 0.2 per cent.
Fear gauge India VIX spiked over 13 per cent.
Since the second wave of the pandemic is turning out to be much worse than expected, there is uncertainty about its impact on the economy and markets. The situation may improve if cases peak soon and start coming down. But currently, this is a negative, said an analyst.
“The bad health situation and INR depreciation have improved prospects for the pharma and IT sectors, which are likely to remain resilient even during a market downturn. Economy-facing stocks are likely to be under pressure," said VK Vijayakumar, Chief Investment Strategist at Geojit Financial Services.
FACTORS DRAGGING MARKET
Covid rampage: India added 1,52,879 fresh infections reported since yesterday, setting another grim one-day record as the country's Covid tally reached over 1.33 crore cases on Sunday. 839 deaths in the last 24 hours pushed the total death count to 1.69 lakh.
Yields surge: US Treasury yields climbed on Friday after higher-than-expected March producer price data showed inflation had risen, echoing other reports that said the world's largest economy was on a steady road to recovery from the pandemic.
ADVERTISEMENT
Rising inflation: Data out this week are expected to show US inflation jumped in March, while retail sales are seen surging perhaps even with a double-digit gain. Treasury is also set to test demand with offers of $100 billion in debt this week.How are the blue chip stocks doing?
After opening in the red, benchmark indices nosedived as a broad-based selloff deepened led by financial stocks. BSE flagship Sensex ended 1,707.94 points or 3.44 per cent lower at 47,883.38. NSE benchmark Nifty followed, tumbling 524.05 points or 3.53 per cent to close at 14,310.80.
In the 50-share pack Nifty, Cipla was the biggest gainer, up 2.14 per cent. Infosys, Dr Reddy’s Laboratories and Divi’s Laboratories were among other gainers.
A record surge in Covid-19 infections is spooking Dalal Street once again amid weakness across global markets, as investors await the onset of the corporate earnings back home. Anticipating strong stock-specific action, analysts have made a few recommendations that they believe can help investors bag handsome returns in the coming weeks.
ADVERTISEMENT
Broader markets
Broader market indices were trading with cuts deeper than their headline peers in morning deals. Nifty Smallcap was down 4.52 per cent while Nifty Midcap declined 4.42 per cent. The broadest index on NSE -- the Nifty 500 index -- was down 2.97 per cent.
ADVERTISEMENT
Dr Lal Pathlabs, Mindtree, Ipca Labs and Thyrocare Technologies were gainers from the space while Sterlite Tech, India Cements, Sterling wilson Solar, RBL Bank, M&M Financials Services and Bank of Baroda were under selling pressure.Global markets
MSCI's broadest index of Asia-Pacific shares outside Japan was off 0.6 per cent in slow trade. Tokyo's Nikkei edged down 0.5 per cent, while South Korean stocks were near flat.
Chinese blue chips eased 0.9 per cent ahead of a rush of economic figures from the country.
Nasdaq futures slipped 0. per cent on Monday, as did S&P 500 futures. EUROSTOXX 50 futures dithered on either side of flat, while FTSE futures were down 0.2 per cent.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
